nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Additive Effect of TAK-491, a New Angiotensin Receptor Blocker, and Pioglitazone, in Reducing Myocardial Infarct Size
|
Ye, Yumei |
|
2010 |
24 |
2 |
p. 107-120 |
artikel |
2 |
A Multicenter, Eight-Week Treatment, Single-Step Titration, Open-Label Study Assessing the Percentage of Korean Dyslipidemic Patients Achieving LDL Cholesterol Target with Atorvastatin Starting Doses of 10 mg, 20 mg and 40 mg
|
Lee, Cheol Whan |
|
2010 |
24 |
2 |
p. 181-188 |
artikel |
3 |
Application of Direct Renin Inhibition to Chronic Kidney Disease
|
Mende, Christian W. |
|
2010 |
24 |
2 |
p. 139-149 |
artikel |
4 |
Cardiovascular Risks of Anemia Correction with Erythrocyte Stimulating Agents: Should Blood Viscosity Be Monitored for Risk Assessment?
|
Jeong, Seul-Ki |
|
2010 |
24 |
2 |
p. 151-160 |
artikel |
5 |
Granulocyte-colony Stimulating Factor Treatment of Chronic Myocardial Infarction
|
Louzada, Ruy A. N. |
|
2010 |
24 |
2 |
p. 121-130 |
artikel |
6 |
Hydralazine does not Ameliorate Nitric Oxide Resistance in Chronic Heart Failure
|
Chirkov, Yuliy Y. |
|
2010 |
24 |
2 |
p. 131-137 |
artikel |
7 |
Hypoxia Inducible Factor-1 Protects Against Nitrate Tolerance and Stunning in Rabbit Cardiac Myocytes
|
Tan, Tao |
|
2010 |
24 |
2 |
p. 95-106 |
artikel |
8 |
Practical Strategies for the Management of Anticoagulation Therapy: Unsolved Issues in the Cardiac Catheterization Laboratory
|
Díez, José G. |
|
2010 |
24 |
2 |
p. 161-174 |
artikel |
9 |
Rationale, design and population baseline characteristics of the PERFORM Vascular Project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) trial
|
Hennerici, Michael G. |
|
2010 |
24 |
2 |
p. 175-180 |
artikel |